Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ORGN vs BIOX

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ORGN
Origin Materials, Inc.

Chemicals

Basic MaterialsNASDAQ • US
Market Cap$211M
5Y Perf.-99.5%
BIOX
Bioceres Crop Solutions Corp.

Agricultural Inputs

Basic MaterialsNASDAQ • AR
Market Cap$30M
5Y Perf.-91.2%

ORGN vs BIOX — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ORGN logoORGN
BIOX logoBIOX
IndustryChemicalsAgricultural Inputs
Market Cap$211M$30M
Revenue (TTM)$25M$318M
Net Income (TTM)$-69M$-53M
Gross Margin1.8%39.1%
Operating Margin-321.3%0.2%
Total Debt$10M$277M
Cash & Equiv.$56M$33M

ORGN vs BIOXLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ORGN
BIOX
StockSep 20May 26Return
Origin Materials, I… (ORGN)1000.5-99.5%
Bioceres Crop Solut… (BIOX)1008.8-91.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: ORGN vs BIOX

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BIOX leads in 3 of 6 categories, making it the strongest pick for profitability and margin quality and recent price momentum and sentiment. Origin Materials, Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
ORGN
Origin Materials, Inc.
The Income Pick

ORGN is the clearest fit if your priority is income & stability and growth exposure.

  • beta 1.68
  • Rev growth 8.6%, EPS growth -441.2%
  • Lower volatility, beta 1.68, Low D/E 2.9%, current ratio 11.09x
Best for: income & stability and growth exposure
BIOX
Bioceres Crop Solutions Corp.
The Long-Run Compounder

BIOX carries the broadest edge in this set and is the clearest fit for long-term compounding.

  • -95.1% 10Y total return vs ORGN's -99.5%
  • -16.6% margin vs ORGN's -275.0%
  • -88.5% vs ORGN's -92.8%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthORGN logoORGN8.6% revenue growth vs BIOX's -28.3%
Quality / MarginsBIOX logoBIOX-16.6% margin vs ORGN's -275.0%
Stability / SafetyORGN logoORGNBeta 1.68 vs BIOX's 1.94, lower leverage
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)BIOX logoBIOX-88.5% vs ORGN's -92.8%
Efficiency (ROA)BIOX logoBIOX-6.7% ROA vs ORGN's -19.7%, ROIC -0.5% vs -19.6%

ORGN vs BIOX — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ORGNOrigin Materials, Inc.
FY 2024
Product
100.0%$31M
Service
0.0%$3,000
BIOXBioceres Crop Solutions Corp.

Segment breakdown not available.

ORGN vs BIOX — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBIOXLAGGINGORGN

Income & Cash Flow (Last 12 Months)

BIOX leads this category, winning 5 of 6 comparable metrics.

BIOX is the larger business by revenue, generating $318M annually — 12.7x ORGN's $25M. Profitability is closely matched — net margins range from -16.6% (BIOX) to -2.8% (ORGN). On growth, BIOX holds the edge at -16.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricORGN logoORGNOrigin Materials,…BIOX logoBIOXBioceres Crop Sol…
RevenueTrailing 12 months$25M$318M
EBITDAEarnings before interest/tax-$70M$21M
Net IncomeAfter-tax profit-$69M-$53M
Free Cash FlowCash after capex-$55M$37M
Gross MarginGross profit ÷ Revenue+1.8%+39.1%
Operating MarginEBIT ÷ Revenue-3.2%+0.2%
Net MarginNet income ÷ Revenue-2.8%-16.6%
FCF MarginFCF ÷ Revenue-2.2%+11.5%
Rev. Growth (YoY)Latest quarter vs prior year-43.2%-16.4%
EPS Growth (YoY)Latest quarter vs prior year+57.7%-37.3%
BIOX leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

BIOX leads this category, winning 2 of 3 comparable metrics.
MetricORGN logoORGNOrigin Materials,…BIOX logoBIOXBioceres Crop Sol…
Market CapShares × price$211M$30M
Enterprise ValueMkt cap + debt − cash$164M$274M
Trailing P/EPrice ÷ TTM EPS-2.45x-0.58x
Forward P/EPrice ÷ next-FY EPS est.
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple20.01x
Price / SalesMarket cap ÷ Revenue6.74x0.09x
Price / BookPrice ÷ Book value/share0.60x0.10x
Price / FCFMarket cap ÷ FCF0.85x
BIOX leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

BIOX leads this category, winning 6 of 9 comparable metrics.

BIOX delivers a -16.7% return on equity — every $100 of shareholder capital generates $-17 in annual profit, vs $-22 for ORGN. ORGN carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to BIOX's 0.94x. On the Piotroski fundamental quality scale (0–9), BIOX scores 3/9 vs ORGN's 2/9, reflecting mixed financial health.

MetricORGN logoORGNOrigin Materials,…BIOX logoBIOXBioceres Crop Sol…
ROE (TTM)Return on equity-21.9%-16.7%
ROA (TTM)Return on assets-19.7%-6.7%
ROICReturn on invested capital-19.6%-0.5%
ROCEReturn on capital employed-20.8%-0.8%
Piotroski ScoreFundamental quality 0–923
Debt / EquityFinancial leverage0.03x0.94x
Net DebtTotal debt minus cash-$47M$244M
Cash & Equiv.Liquid assets$56M$33M
Total DebtShort + long-term debt$10M$277M
Interest CoverageEBIT ÷ Interest expense-417.10x-0.07x
BIOX leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

BIOX leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in BIOX five years ago would be worth $317 today (with dividends reinvested), compared to $48 for ORGN. Over the past 12 months, BIOX leads with a -88.5% total return vs ORGN's -92.8%. The 3-year compound annual growth rate (CAGR) favors BIOX at -64.0% vs ORGN's -77.7% — a key indicator of consistent wealth creation.

MetricORGN logoORGNOrigin Materials,…BIOX logoBIOXBioceres Crop Sol…
YTD ReturnYear-to-date-79.9%-65.0%
1-Year ReturnPast 12 months-92.8%-88.5%
3-Year ReturnCumulative with dividends-98.9%-95.3%
5-Year ReturnCumulative with dividends-99.5%-96.8%
10-Year ReturnCumulative with dividends-99.5%-95.1%
CAGR (3Y)Annualised 3-year return-77.7%-64.0%
BIOX leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — ORGN and BIOX each lead in 1 of 2 comparable metrics.

ORGN is the less volatile stock with a 1.68 beta — it tends to amplify market swings less than BIOX's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BIOX currently trades 9.1% from its 52-week high vs ORGN's 5.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricORGN logoORGNOrigin Materials,…BIOX logoBIOXBioceres Crop Sol…
Beta (5Y)Sensitivity to S&P 5001.68x1.94x
52-Week HighHighest price in past year$28.49$5.18
52-Week LowLowest price in past year$0.20$0.35
% of 52W HighCurrent price vs 52-week peak+5.0%+9.1%
RSI (14)Momentum oscillator 0–10030.744.6
Avg Volume (50D)Average daily shares traded161K804K
Evenly matched — ORGN and BIOX each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricORGN logoORGNOrigin Materials,…BIOX logoBIOXBioceres Crop Sol…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$90.00
# AnalystsCovering analysts6
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+3.1%
Insufficient data to determine a leader in this category.
Key Takeaway

BIOX leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 1 category is tied.

Best OverallBioceres Crop Solutions Cor… (BIOX)Leads 4 of 6 categories
Loading custom metrics...

ORGN vs BIOX: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is ORGN or BIOX a better buy right now?

For growth investors, Origin Materials, Inc.

(ORGN) is the stronger pick with 8. 6% revenue growth year-over-year, versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). Analysts rate Origin Materials, Inc. (ORGN) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ORGN or BIOX?

Over the past 5 years, Bioceres Crop Solutions Corp.

(BIOX) delivered a total return of -96. 8%, compared to -99. 5% for Origin Materials, Inc. (ORGN). Over 10 years, the gap is even starker: BIOX returned -95. 1% versus ORGN's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ORGN or BIOX?

By beta (market sensitivity over 5 years), Origin Materials, Inc.

(ORGN) is the lower-risk stock at 1. 68β versus Bioceres Crop Solutions Corp. 's 1. 94β — meaning BIOX is approximately 15% more volatile than ORGN relative to the S&P 500. On balance sheet safety, Origin Materials, Inc. (ORGN) carries a lower debt/equity ratio of 3% versus 94% for Bioceres Crop Solutions Corp. — giving it more financial flexibility in a downturn.

04

Which is growing faster — ORGN or BIOX?

By revenue growth (latest reported year), Origin Materials, Inc.

(ORGN) is pulling ahead at 8. 6% versus -28. 3% for Bioceres Crop Solutions Corp. (BIOX). On earnings-per-share growth, the picture is similar: Origin Materials, Inc. grew EPS -441. 2% year-over-year, compared to -1704. 7% for Bioceres Crop Solutions Corp.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ORGN or BIOX?

Bioceres Crop Solutions Corp.

(BIOX) is the more profitable company, earning -15. 5% net margin versus -267. 6% for Origin Materials, Inc. — meaning it keeps -15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BIOX leads at -1. 1% versus -271. 3% for ORGN. At the gross margin level — before operating expenses — BIOX leads at 39. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — ORGN or BIOX?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is ORGN or BIOX better for a retirement portfolio?

For long-horizon retirement investors, Origin Materials, Inc.

(ORGN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Bioceres Crop Solutions Corp. (BIOX) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ORGN: -99. 5%, BIOX: -95. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between ORGN and BIOX?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ORGN

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
Run This Screen
Stocks Like

BIOX

Quality Business

  • Sector: Basic Materials
  • Market Cap > $100B
  • Gross Margin > 23%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform ORGN and BIOX on the metrics below

Revenue Growth>
%
(ORGN: -43.2% · BIOX: -16.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.